EGFR and its ligand, transforming growth factor-alpha (TGF-alpha) play an important role in several human cancers [105,106], through the autocrine growth-regulation system in breast cancer, EGFR has been reported to be associated with a poor clinical outcome [107,108]. This evidence concerns the gene EGFR and breast carcinoma.